Mucosal delivery of the human immunodeficiency virus-1 Tat protein in mice elicits systemic neutralizing antibodies, cytotoxic T lymphocytes and mucosal IgA

Author： Marinaro M.   Riccomi A.   Rappuoli R.   Pizza M.   Fiorelli V.   Tripiciano A.   Cafaro A.   Ensoli B.   De Magistris M.T.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.21, Iss.25, 2003-09, pp. : 3972-3981

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunization of mice with recombinant gp41 in a systemic prime/mucosal boost protocol induces HIV-1-specific serum IgG and secretory IgA antibodies

By Mantis N.J.   Kozlowski  

Vaccine, Vol. 19, Iss. 28, 2001-07 ,pp. : 3990-4001

Elsevier

Access to resources Recommend Favorite

Red blood cell-mediated delivery of recombinant HIV-1 Tat protein in mice induces anti-Tat neutralizing antibodies and CTL

By Dominici S.   Laguardia M.E.   Serafini G.   Chiarantini L.   Fortini C.   Tripiciano A.   Brocca-Cofano E.   Scoglio A.   Caputo A.   Fiorelli V.   Gavioli R.   Cafaro A.   Ensoli B.   Magnani M.  

Vaccine, Vol. 21, Iss. 17, 2003-05 ,pp. : 2082-2090

Elsevier

Access to resources Recommend Favorite

Induction of mucosal IgA by a novel jet delivery technique for HIV-1 DNA

By Lundholm P.   Asakura Y.   Hinkula J.   Lucht E.   Wahren B.  

Vaccine, Vol. 17, Iss. 15, 1999-04 ,pp. : 2036-2042

Elsevier

Access to resources Recommend Favorite

Vaccine-induced cytotoxic T lymphocytes against human immunodeficiency virus type 1 using two complementary in vitro stimulation strategies

By Gorse G.J.   Patel G.B.   Mandava M.D.   Belshe R.B.  

Vaccine, Vol. 18, Iss. 9, 1999-12 ,pp. : 835-849

Elsevier

Access to resources Recommend Favorite

Oral vaccination of mice with human papillomavirus virus-like particles induces systemic virus-neutralizing antibodies

By Rose R.C.   Lane C.   Wilson S.   Suzich J.A.   Rybicki E.   Williamson A.-L.  

Vaccine, Vol. 17, Iss. 17, 1999-04 ,pp. : 2129-2135

Elsevier

Access to resources Recommend Favorite